TP53 and ovarian carcinoma: The study design selected HGSOC and EC cases for TP53 sequencing and p53 IHC from two ovarian carcinoma cohorts available on tissue microarrays that had been subjected to detailed pathology review and immunophenotyping to accurately determine histotype.